Daniel Dreidax
Impact in
- Neurology top 10%
- Neuroblastoma Research and Treatments
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 10
- Neuroblastoma Research and Treatments 10
-
- Signaling Pathways in Disease 2
- Protein Degradation and Inhibitors 2
- Epigenetics and DNA Methylation 1
- Chromatin Remodeling and Cancer 1
- Co-authors
- Frank Westermann (10 shared papers)Matthias Fischer (5 shared papers)Boris Ν. Kholodenko (1 shared paper)Ruth Pilkington (1 shared paper)Amaya Garcia Muñoz (1 shared paper)Dirk Fey (1 shared paper)David R. Croucher (1 shared paper)Walter Kölch (1 shared paper)
- Journals
- Human Molecular Genetics (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Oncology (1 paper)Gene (1 paper)Cell Cycle (1 paper)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Daniel Dreidax
12 papers receiving 442 citations
Peers
Comparison fields: 5 of 74
- Neurology 185
- Cancer Research 138
- Molecular Biology 308
- Oncology 104
- Modeling and Simulation 11
Countries citing papers authored by Daniel Dreidax
This map shows the geographic impact of Daniel Dreidax's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Dreidax with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Dreidax more than expected).
Fields of papers citing papers by Daniel Dreidax
This network shows the impact of papers produced by Daniel Dreidax. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Dreidax. The network helps show where Daniel Dreidax may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Dreidax, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 116 | |
| 2 | 2016 | 73 | |
| 3 | 2012 | 64 | |
| 4 | 2011 | 61 | |
| 5 | 2013 | 52 | |
| 6 | 2015 | 31 | |
| 7 | 2014 | 20 | |
| 8 | 2013 | 10 | |
| 9 | 2010 | 9 | |
| 10 | 2016 | 6 | |
| 11 | 2021 | 3 | |
| 12 | 2014 | 1 |
About Daniel Dreidax
Daniel Dreidax is a scholar working on Neurology, Molecular Biology, Cancer Research, Oncology and Endocrine and Autonomic Systems, having authored 12 papers that have together received 446 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (10 papers), Cancer, Hypoxia, and Metabolism (6 papers), Cancer-related Molecular Pathways (4 papers), Signaling Pathways in Disease (2 papers), Protein Degradation and Inhibitors (2 papers), Epigenetics and DNA Methylation (1 paper), Neuroscience of respiration and sleep (1 paper) and Chromatin Remodeling and Cancer (1 paper). The work is most often cited by research in Neurology (185 citations), Cancer Research (138 citations), Molecular Biology (308 citations), Oncology (104 citations) and Modeling and Simulation (11 citations). Daniel Dreidax has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Frank Westermann, Matthias Fischer, Boris Ν. Kholodenko, Ruth Pilkington, Amaya Garcia Muñoz, Dirk Fey, David R. Croucher, Walter Kölch, Volker Ehemann and Sean P. Kennedy. Their work appears in journals such as Human Molecular Genetics, Molecular Cancer Therapeutics, Molecular Oncology, Gene and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.